Alkermes plc Overview
Alkermes plc Target Price
Analysts' 12-month price predictions for ALKS.
Get informed when a big investor buys or sells
+ FollowShare Price
$48.07
Average Target Price
$50.75
5.6% upside
5.6% upside4 analysts in the last 4 months
High: $56 | Low: $43
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-18 | NeedhamAmi Fadia | $54 | 12.3% upside |  |
| 2026-06-09 | RBC CapitalLeonid Timashev | $56 | 16.5% upside | |
| 2026-05-06 | Needham | $50 | 4% upside | |
| 2026-02-26 | H.C. WainwrightDouglas Tsao | $43 |  10.5% downside | |
| 2026-02-23 | Wolfe Research | $45 | 6.4% downside | |
| 2025-10-28 | JefferiesAkash Tewari | $56 | 16.5% upside | |
| 2025-10-27 | Mizuho Securities | $45 | 6.4% downside | |
| 2025-10-23 | Piper SandlerDavid Amsellem | $45 | 6.4% downside | |
| 2025-10-22 | RBC Capital | $47 | 2.2% downside | |
| 2025-09-26 | RBC CapitalAlkermes to Outperform | $44 | 8.5% downside | |
| 2025-09-09 | Needham | $43 | 10.5% downside | |
| 2025-09-09 | H.C. WainwrightDouglas Tsao | $46 | 4.3% downside | |
| 2025-09-02 | Wells Fargo | $44 | 8.5% downside | |
| 2025-06-17 | UBSAshwani Verma | $42 | 12.6% downside | |
| 2024-12-05 | Piper SandlerDavid Amsellem | $37 | 23% downside | |
| 2024-11-13 | Mizuho SecuritiesVamil Divan | $40 | 16.8% downside | |
| 2024-11-04 | Stifel NicolausPaul Matteis | $36 | 25.1% downside | |
| 2024-10-24 | Stifel NicolausPaul Matteis | $25 | 48% downside | |
| 2024-10-14 | H.C. WainwrightDouglas Tsao | $37 | 23% downside | |
| 2024-04-10 | JefferiesAkash Tewari | $25 | 48% downside | |
| 2024-04-09 | Mizuho SecuritiesVamil Divan | $35 | 27.2% downside | |
| 2024-04-09 | JefferiesAkash Tewari | $25 | 48% downside | |
| 2024-03-18 | Robert W. BairdJoel Beatty | $37 | 23% downside | |
| 2022-12-06 | J.P. Morgan | $29 | 39.7% downside | |
| 2022-04-28 | Leerink Partners | $27 | 43.8% downside | |
| 2022-04-21 | Leerink Partners | $25 | 48% downside | |
| 2022-04-20 | Goldman Sachs | $35 | 27.2% downside | |